1. Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet. 2001: 357: 1349–53.
2. Atkins CD. Dissection of regional lymph nodes in cutaneous melanoma [letter]. Lancet 1998; 351: 1884–5.
3. Shakespeare TP. Dissection of regional lymph nodes in cutaneous melanoma [letter]. Lancet 1998; 351: 1885.
4. Cates CJ. Systematic review of trials comparing antibiotic with placebo for acute cough in adults. Data do not justify study’s conclusions [letter]. Br Med J 1998; 317: 1014.
5. Shakespeare TP, Bourke RC. Systematic review of trials comparing antibiotic with placebo for acute cough in adults. Too few subjects were studied for useful conclusions to be drawn [letter]. BMJ 1998; 317: 1014–15.
6. Braitman LE. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med, 1991; 114: 515–17.
7. Altman DG, Gardner MJ. Confidence intervals for research findings. Br J Obstet Gynaecol 1992; 99: 90–1.
8. Berry G. Statistical significance and confidence intervals. Med J Aust 1986; 144: 618–19.
9. Bulpitt CJ. Confidence intervals. Lancet 1987; i: 494–7.
10. Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. Br Med J 1986; 292: 810–12.
11. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997; 336: 309–15.
12. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986; 105: 429–35.
13. Braitman LE. Confidence intervals extract clinically useful information from data. Ann Intern Med 1988; 108: 296–8.
14. Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999; 130: 995–1004.
15. DeRouen TA. Statistical testing and confidence intervals (Letter). Am J Public Health 1987;77:237.
16. P. Landais, J-P. Daures, Clinical trials, immunosuppression and renal transplantation: new trends in design and analysis, Pediatr. Nephrol. 17 (2002) 573-584.
17. G. Bouvenot, P. Villani, P. Ambrosi, Critical review of the publication of a clinical trial, Presse. Med. 31 (2002) 1061-1068.
18. G. Bouvenot. How to minimize the therapeutic risk, Rev. Med. Interne. 22 (2001) 1237-1243.
19. A. Hernandez Jerez, From case report to epidemiological evidence of causality in biomedical research, Arbor 171 (2002) 589-608.
20. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F, on behalf of the WHO Melanoma Programme. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 1998; 351: 793–6.
21. A.M.H. Ho, A. Lee, E. Ling, A. Daly, K. Teoh, T.E. Warkentin, Agreements between the prothrombin times of blood treated in vitro with heparinase during cardiopulmonary bypass (CPB) and blood sampled after CPB and systemic protamine, Anesth. Analg. 96 (2003) 15-20.
22. A.M.H. Ho, A. Lee, M.K. Karmakar, P.W. Dion, D.C. Chung, L.H. Contardi, Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma – a systematic overview, Chest 123 (2003) 882-890.
23. Al-Sarraf M, LeBlanc M, Giri PGS et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310–17.
24. Shakespeare’s Confidence Level Calculator v 1.0. Free downloadable file from www.theshakespeares.com/confidence_calculator.html

Go to Comment Form